Updated guidelines recommend fidaxomicin as the first-line agent for C difficile infection, but researchers found use in US ...

An mRNA vaccine that targets several aspects of C. difficile’s ability to cause severe disease prevented major symptoms and death in mice.

In the period spanning 2017-2021, a mere 12 new antibiotics entered the market, with only one capable of targeting all the ...

Mild Clostridium difficile infection (CDI; stool frequency <four-times daily; no signs of severe colitis), clearly induced by the use of antibiotics, may be treated by stopping the inducing ...

diff infection. It's critical for antibiotics to kill dangerous bacteria while leaving the healthy flora in our bodies alone. In fact, C. diff infections often spring up because the bacteria take ...

The product is based on purified Firmicutes bacterial spores delivered in an oral capsule that is designed to encourage the regrowth of healthy bacteria after antibiotic treatment for C.

H. pylori infections occur across the world due to exposure to saliva or stool in contaminated water or food. Learn how the ...

Discover Merck's groundbreaking patent on genetic markers linked to enhanced C. difficile treatment responses. Learn how personalized therapy can improve patient outcomes.

Adults with three or more diarrheal stools (defined as liquid or unformed) per day or six or more diarrheal stools in a 36-hour period and a positive result for C. difficile toxin by enzyme ...